Welcome to our dedicated page for Privia Health Group news (Ticker: PRVA), a resource for investors and traders seeking the latest updates and insights on Privia Health Group stock.
Privia Health Group, Inc. (PRVA) delivers technology-enabled physician partnership solutions transforming healthcare delivery. This news hub provides investors and industry observers with essential updates on the company's operational developments and strategic direction.
Access timely PRVA press releases covering earnings announcements, value-based care initiatives, and technology partnerships. Our curated collection helps stakeholders track:
• Financial Updates: Quarterly results and SEC filings
• Operational Milestones: Practice network expansions and platform enhancements
• Strategic Collaborations: Health system partnerships and technology integrations
• Industry Recognition: Awards and quality care achievements
Bookmark this page for objective reporting on PRVA's physician enablement strategies and cloud-based healthcare solutions. Verify compliance updates and leadership changes through our maintained news archive.
Privia Health Group (Nasdaq: PRVA) reported strong Q2 2024 financial results, with notable growth across key metrics. Total revenue increased 2.2% to $422.3 million, while gross profit rose 8.9% to $98.3 million. The company saw a 16.4% increase in implemented providers to 4,504 and a 10.7% growth in value-based care attributed lives to 1.2 million. Adjusted EBITDA grew 14% to $22 million, and non-GAAP adjusted net income increased 13% to $23.5 million.
Based on strong performance, Privia Health raised its full-year 2024 guidance to the mid to high end for all metrics. The company maintains a robust financial position with $387.4 million in cash and no debt. These results demonstrate Privia Health's continued execution and growth in the healthcare sector.
Privia Health Group (Nasdaq: PRVA) will release its financial results for Q2 and the six-month period ending June 30, 2024, on August 8, 2024, before market open. The press release will be available on the company's Investor Relations website, expected by 7:00 am ET. Management will host a conference call at 8:00 am ET the same day to discuss the results and future outlook. The call will be accessible via live webcast and archived for replay on the Investor Relations site. Dial 800-715-9871 (646-307-1963 for international) with Conference ID 2580381 to join the live call.
Privia Health Group announced that Privia Medical Group received the 2024 MAP Award for High Performance in Revenue Cycle from the Healthcare Financial Management Association (HFMA). This marks the eighth recognition in nine years for the group, highlighting its robust revenue cycle capabilities and adherence to industry standards. The award was presented on June 24 at the HFMA Annual Conference in Las Vegas. Privia's success is attributed to its implementation of HFMA's Healthcare Dollars & Sense® initiatives, which focus on patient-centered best practices and benchmarks. The achievement underscores the dedication of Privia's physicians and staff to operational excellence and patient satisfaction.
On May 30, 2024, Privia Health Group (Nasdaq: PRVA) announced its participation in the 44th Annual William Blair Growth Stock Conference.
The presentation by the management team is scheduled for June 5, 2024, at 11:00 am ET / 10:00 am CT.
The live webcast and replay will be accessible on Privia Health's investor relations website.
Privia Health Group, Inc. (Nasdaq: PRVA) reported a 7.5% increase in total revenue, with gross profit up by 12.5% and non-GAAP adjusted net income rising by 16.6% in the first quarter of 2024. The company also saw an increase of 17.3% in implemented providers and reiterated its full-year 2024 guidance.
FAQ
What is the current stock price of Privia Health Group (PRVA)?
What is the market cap of Privia Health Group (PRVA)?
